EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Advances in Vascularization of Islet Organoids: Engineering Strategies, Functional Evaluation, and Transplantation Applications

Xiaoying Qu, Hongxuan Li, Bojia Li, Xin Liu, Wei Jia, Qiyan Jin, Wei Huang, Zheyi Xu, Yanhui Cen

American Journal of Bioinformatics · 15.04.2026 · 7 (1) · 84-94

DOI: 10.71465/ajb.3670 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Bioinformatics, online erschienen am 15.04.2026. Verfasst von Xiaoying Qu und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The growth and evolution of diabetes, especially Type 1 and Type 2, are highly correlated to the failure of islet β cells and consequently replacing of β cells is an area of interest in research. In recent years, stem cell-based islet organoids have offered a novel therapeutic approach to diabetes treatment; nevertheless, additional functional development and clinical use remain restricted due to the absence of vascular microenvironment. The present paper discusses main engineering strategies, evaluation parameters, revascularization after transplantation and clinical translation issues concerning vascularization of islet organoids. Recent vascularization methods have largely involved co-culturing with vascular-associated cells, building vascular organoids and multi-lineage co-differentiation. Such strategies have been shown to have some success at promoting beta-cell maturation, increasing glucose sensitivity, and boosting post-transplantation survival rates. However, at this stage of development, research has faced the challenge of insufficient vascular maturity, poor long-term perfusion performance, low efficiency of integration in vivo, and the challenge of achieving both immune protection and fast vascularization. Further studies should be conducted to create working vascular systems and reach synergistic optimization in immune regulation, anti-fibrosis design and standardized preparation to promote the clinical use of islet organoids in cellular replacement therapy in diabetes.

Zitieren

APA

Qu, X., Li, H., Li, B., Liu, X., Jia, W., Jin, Q., Huang, W., Xu, Z., & Cen, Y. (2026). Advances in Vascularization of Islet Organoids: Engineering Strategies, Functional Evaluation, and Transplantation Applications. American Journal of Bioinformatics, 7(1), 84-94. https://doi.org/10.71465/ajb.3670

Vancouver

Qu X, Li H, Li B, Liu X, Jia W, Jin Q, et al. Advances in Vascularization of Islet Organoids: Engineering Strategies, Functional Evaluation, and Transplantation Applications. American Journal of Bioinformatics. 2026;7(1):84-94. doi:10.71465/ajb.3670

BibTeX
@article{Qu2026,
  author = {Qu, Xiaoying and Li, Hongxuan and Li, Bojia and Liu, Xin and Jia, Wei and Jin, Qiyan and Huang, Wei and Xu, Zheyi and Cen, Yanhui},
  title = {Advances in Vascularization of Islet Organoids: Engineering Strategies, Functional Evaluation, and Transplantation Applications},
  journal = {American Journal of Bioinformatics},
  year = {2026},
  volume = {7},
  number = {1},
  pages = {84--94},
  doi = {10.71465/ajb.3670}
}
Kostenlos starten →